#Industrial Biotech #Biomanufacturing / Pharmaceutical Services #R&D Services and Products #Therapeutics
- Recombinant antibodies
- Therapeutic proteins
- Transient expression
- plant system
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >#Industrial Biotech #Biomanufacturing / Pharmaceutical Services #R&D Services and Products #Therapeutics
R&D services in the field of transient expression of recombinant proteins in plants.
BACKGROUND
Created in April 2017, Pymabs is a spin-off of the Genopole Plant Process Innovation laboratory.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Benefiting from Medicago’s high-throughput discovery platform (VLPExpress), Pymabs provides proofs of concepts for antibody expression in the setting of therapeutics. Its services range from antibody development to in vitro testing .
CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
Collaboration with Medicago (Canadian Biopharmaceutical company).
COLLABORATIONS SOUGHT
Companies developing antibodies for therapeutic purposes and wishing to test an alternative biomanufacturing approach on an industrial scale.
ANNUAL TURNOVER: 380 k€
1 Patent being written
3 Staff members
< strong >STRENGTHS:
Speedy development and rapid transfer from R&D to bioproduction.
< strong >INNOVATION ASSETS:
Glycomodulation.
In same field